Pancreatic Cancer Research

ResearcherAsan Medical CenterNo recent work listed

Jae‐Lyun Lee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9420-7162; OpenAlex author ID A5063838757. Sources: ClinicalTrials.gov.

Their work

Papers
5
Trials
2 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2006: 1 trial · 2007: 1 trial · 2008: none · 2009: none · 2010: none · 2011: none · 2012: 3 papers · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper

Papers 5

  1. Germline BRCA mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing. Co-author DOI 10.1007/s10637-017-0497-1↗
  2. Efficacy and safety of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: improved efficacy compared with gemcitabine-based regimen. Co-author DOI 10.18632/oncotarget.17940↗
  3. Prospective efficacy and safety study of neoadjuvant gemcitabine with capecitabine combination chemotherapy for borderline-resectable or unresectable locally a… Co-author DOI 10.1016/j.surg.2012.03.010↗
  4. YM155 induces EGFR suppression in pancreatic cancer cells. Co-author DOI 10.1371/journal.pone.0038625↗
  5. The survivin suppressant YM155 potentiates chemosensitivity to gemcitabine in the human pancreatic cancer cell line MiaPaCa-2. Co-author PMID 22593446↗

Trials 2

  1. Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer Study chair NCT00786006↗
  2. Neoadjuvant FDR GX in Locally Advanced Pancreatic Cancer Principal investigator NCT01268384↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Do Hyun Park · 3 shared papers, 2012–2018 · strength 0.14
  2. Myung‐Hwan Kim · 3 shared papers, 2012–2018 · strength 0.14
  3. Dong Wan Seo · 3 shared papers, 2012–2018 · strength 0.14
  4. Sang Soo Lee · 3 shared papers, 2012–2018 · strength 0.14
  5. Song Cheol Kim · 3 shared papers, 2012–2018 · strength 0.14
  6. Ki Byung Song · 2 shared papers, 2017–2018 · strength 0.12
  7. Kyu‐pyo Kim · 2 shared papers, 2017–2018 · strength 0.12
  8. Tae Won Kim · 3 shared papers, 2012–2018 · strength 0.12
  9. Dae Wook Hwang · 2 shared papers, 2017–2018 · strength 0.12
  10. Tae Jun Song · 2 shared papers, 2017–2018 · strength 0.12
  11. Baek‐Yeol Ryoo · 2 shared papers, 2017–2018 · strength 0.12
  12. Changhoon Yoo · 2 shared papers, 2017–2018 · strength 0.12
  13. Sang Hyun Shin · 2 shared papers, 2012–2018 · strength 0.09
  14. Jin‐hong Park · 2 shared papers, 2012–2017 · strength 0.08
  15. Kyoungmin Lee · 1 shared paper, 2018 · strength 0.06
  16. W. Lee · 1 shared paper, 2018 · strength 0.06
  17. JiHoon Kang · 1 shared paper, 2017 · strength 0.06
  18. Dok Hyun Yoon · 2 shared papers, 2012 · strength 0.06
  19. Young-Soon Na · 1 shared paper, 2012 · strength 0.03
  20. Jong Hoon Kim · 1 shared paper, 2012 · strength 0.03
  21. Duck Jong Han · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.